메뉴 건너뛰기




Volumn 49, Issue 4, 2005, Pages 1556-1560

Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of Chagas' disease

Author keywords

[No Author keywords available]

Indexed keywords

2 [2 (2,4 DIFLUOROPHENYL) 2 HYDROXY 1 METHYL 3 (1H 1,2,4 TRIAZOL 1 YL)PROPYL] 4 [4 (2,2,3,3 TETRAFLUOROPROPOXY)PHENYL] 1,2,4 TRIAZOL 3(2H) ONE; BENZNIDAZOLE; ERGOSTEROL; NIFURTIMOX; TRIAZOLE DERIVATIVE;

EID: 16244418371     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.4.1556-1560.2005     Document Type: Article
Times cited : (42)

References (15)
  • 2
    • 0027428255 scopus 로고
    • A simple protocol for the physical cleavage of Trypanosoma cruzi kinetoplast DNA present in blood samples and its use in polymerase chain reaction (PCR)-based diagnosis of chronic Chagas disease
    • Britto, C., M. A. Cardoso, P. Wincker, and C. M. Morel. 1993. A simple protocol for the physical cleavage of Trypanosoma cruzi kinetoplast DNA present in blood samples and its use in polymerase chain reaction (PCR)-based diagnosis of chronic Chagas disease. Mem. Inst. Oswaldo Cruz 88:171-172.
    • (1993) Mem. Inst. Oswaldo Cruz , vol.88 , pp. 171-172
    • Britto, C.1    Cardoso, M.A.2    Wincker, P.3    Morel, C.M.4
  • 3
    • 0036359943 scopus 로고    scopus 로고
    • A critical review on Chagas disease chemotherapy
    • Coura, J. R., and S. L. de Castro. 2002. A critical review on Chagas disease chemotherapy. Mem. Inst. Oswaldo Cruz 97:3-24.
    • (2002) Mem. Inst. Oswaldo Cruz , vol.97 , pp. 3-24
    • Coura, J.R.1    De Castro, S.L.2
  • 4
    • 0036162789 scopus 로고    scopus 로고
    • Pathogenesis of Chagas heart disease: Parasite persistence and autoimmune responses versus cardiac remodelling and neurohormonal activation
    • Davila, D. F., O. Rossell, and G. Arata de Bellabarba. 2002. Pathogenesis of Chagas heart disease: parasite persistence and autoimmune responses versus cardiac remodelling and neurohormonal activation. Int. J. Parasitol. 32:107-109.
    • (2002) Int. J. Parasitol. , vol.32 , pp. 107-109
    • Davila, D.F.1    Rossell, O.2    Arata De Bellabarba, G.3
  • 9
    • 0036234361 scopus 로고    scopus 로고
    • Chemotherapy of Chagas disease
    • Urbina, J. A. 2002. Chemotherapy of Chagas disease. Curr. Pharm. Des. 8:287-295.
    • (2002) Curr. Pharm. Des. , vol.8 , pp. 287-295
    • Urbina, J.A.1
  • 10
    • 0038446640 scopus 로고    scopus 로고
    • New chemotherapeutic approaches for the treatment of Chagas disease (American trypanosomiasis)
    • Urbina, J. A. 2003. New chemotherapeutic approaches for the treatment of Chagas disease (American trypanosomiasis). Expert Opin. Ther. Patents 13:661-669.
    • (2003) Expert Opin. Ther. Patents , vol.13 , pp. 661-669
    • Urbina, J.A.1
  • 11
    • 0142227145 scopus 로고    scopus 로고
    • Specific chemotherapy of Chagas disease: Controversies and advances
    • Urbina, J. A., and R. Docampo. 2003. Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol. 19:495-501.
    • (2003) Trends Parasitol. , vol.19 , pp. 495-501
    • Urbina, J.A.1    Docampo, R.2
  • 14
    • 0037220818 scopus 로고    scopus 로고
    • Parasitological cure of acute and chronic experimental Chagas disease using the long-acting experimental triazole TAK-187. Activity against drug-resistant Trypanosoma cruzi strains
    • Urbina, J. A., G. Payares, C. Sanoja, J. Molina, R. Lira, Z. Brener, and A. J. Romanha. 2003. Parasitological cure of acute and chronic experimental Chagas disease using the long-acting experimental triazole TAK-187. Activity against drug-resistant Trypanosoma cruzi strains. Int. J. Antimicrob. Agents 21:39-48.
    • (2003) Int. J. Antimicrob. Agents , vol.21 , pp. 39-48
    • Urbina, J.A.1    Payares, G.2    Sanoja, C.3    Molina, J.4    Lira, R.5    Brener, Z.6    Romanha, A.J.7
  • 15
    • 0036294520 scopus 로고    scopus 로고
    • Control of Chagas disease
    • World Health Organization. 2002. Control of Chagas disease. WHO Tech. Rep. Ser. 905:1-109.
    • (2002) WHO Tech. Rep. Ser. , vol.905 , pp. 1-109


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.